linalool has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Brahma Naidu, P; Chandrasekaran, P; Saravanan, G; Sathibabu Uddandrao, VV; Sengottuvelu, S; Tamilmani, P; Vadivukkarasi, S | 1 |
Al-Okbi, SY; Amin, MA; Edris, AE; Mabrok, HB; Mohamed, AEA; Ramadan, AA; Sharaf, OM | 1 |
2 other study(ies) available for linalool and Non-alcoholic Fatty Liver Disease
Article | Year |
---|---|
Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Fatty Acids; Fatty Liver; Lipid Metabolism; Lipids; Liver; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Sirtuin 1 | 2023 |
Basil Essential Oil and Its Nanoemulsion Mitigate Non Alcoholic Steatohepatitis in Rat Model with Special Reference to Gut Microbiota.
Topics: Acyclic Monoterpenes; Administration, Oral; Animals; Disease Models, Animal; Emulsions; Eucalyptol; Eugenol; Gastrointestinal Microbiome; Lipid Metabolism; Liver; Male; Nanoparticles; Non-alcoholic Fatty Liver Disease; Ocimum; Oils, Volatile; Particle Size; Phytotherapy; Plant Oils; Rats, Sprague-Dawley | 2020 |